Lv2
116 积分 2023-07-03 加入
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
1天前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
2天前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
8个月前
已完结
抗中性粒细胞胞质抗体相关肾炎诊断和治疗中国指南
1年前
已完结
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
1年前
已完结
Acute myeloid leukaemia
1年前
已完结
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
1年前
已完结
[2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus]
1年前
已完结
皖公网安备34019202002308
